These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 19107959

  • 1. DSCG reduces RSV-induced illness in RSV-infected mice.
    Hashimoto K, Mori S, Hashimoto Y, Kaneko H, Ishibashi K, Ishioka K, Kawasaki Y, Peebles RS, Munakata M, Hosoya M, Suzutani T.
    J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
    [Abstract] [Full Text] [Related]

  • 2. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
    Cho JY, Miller M, Baek KJ, Castaneda D, Nayar J, Roman M, Raz E, Broide DH.
    J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
    [Abstract] [Full Text] [Related]

  • 3. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
    Kondo Y, Matsuse H, Machida I, Kawano T, Saeki S, Tomari S, Obase Y, Fukushima C, Kohno S.
    Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
    [Abstract] [Full Text] [Related]

  • 4. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
    Kong X, Hellermann GR, Patton G, Kumar M, Behera A, Randall TS, Zhang J, Lockey RF, Mohapatra SS.
    Virol J; 2005 Feb 08; 2():3. PubMed ID: 15701174
    [Abstract] [Full Text] [Related]

  • 5. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
    Peebles RS, Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, Sheller JR, Graham BS.
    J Infect Dis; 2001 Dec 01; 184(11):1374-9. PubMed ID: 11709778
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
    Ostler T, Ehl S.
    Eur J Immunol; 2002 Sep 01; 32(9):2562-9. PubMed ID: 12207340
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Respiratory syncytial virus persistence: evidence in the mouse model.
    Mejías A, Chávez-Bueno S, Gómez AM, Somers C, Estripeaut D, Torres JP, Jafri HS, Ramilo O.
    Pediatr Infect Dis J; 2008 Oct 01; 27(10 Suppl):S60-2. PubMed ID: 18820580
    [Abstract] [Full Text] [Related]

  • 11. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
    Hirose H, Matsuse H, Fukahori S, Tsuchida T, Tomari S, Kawano T, Fukushima C, Mizuta Y, Kohno S.
    Int Arch Allergy Immunol; 2008 Oct 01; 147(3):197-205. PubMed ID: 18594149
    [Abstract] [Full Text] [Related]

  • 12. [Dingchuantang decoction restores the imbalance of TH2/TH1 in mice infected by respiratory syncytial virus].
    Cui ZZ, Wu ZQ, Wang XF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb 01; 8(1):63-5. PubMed ID: 16522244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
    Zhou J, Yang XQ, Xie YY, Zhao XD, Jiang LP, Wang LJ, Cui YX.
    Virus Res; 2007 Dec 01; 130(1-2):241-8. PubMed ID: 17804108
    [Abstract] [Full Text] [Related]

  • 15. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.
    Vaccine; 2007 Oct 10; 25(41):7132-44. PubMed ID: 17850933
    [Abstract] [Full Text] [Related]

  • 16. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
    Bolger G, Lapeyre N, Dansereau N, Lagacé L, Berry G, Klosowski K, Mewhort T, Liuzzi M.
    Can J Physiol Pharmacol; 2005 Feb 10; 83(2):198-213. PubMed ID: 15791294
    [Abstract] [Full Text] [Related]

  • 17. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L, Mertz S, Gomez AM, Ramilo O, Wittke A, Mejias A.
    Antiviral Res; 2013 Aug 10; 99(2):188-95. PubMed ID: 23735300
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
    Zhang W, Tripp RA.
    J Virol; 2008 Dec 10; 82(24):12221-31. PubMed ID: 18818323
    [Abstract] [Full Text] [Related]

  • 20. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T.
    Biochem Biophys Res Commun; 2009 Apr 17; 381(4):528-32. PubMed ID: 19233131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.